|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1992-12-9
|
|
pubmed:abstractText |
We performed Holter monitoring on days 4 and 7 after acute myocardial infarction in 109 patients to assess whether ST segment shift would identify those with more severe coronary artery disease, left ventricular dysfunction and unfavorable prognosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1313-7
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:1430680-Chi-Square Distribution,
pubmed-meshheading:1430680-Coronary Angiography,
pubmed-meshheading:1430680-Double-Blind Method,
pubmed-meshheading:1430680-Electrocardiography, Ambulatory,
pubmed-meshheading:1430680-Exercise Test,
pubmed-meshheading:1430680-Follow-Up Studies,
pubmed-meshheading:1430680-Heart Catheterization,
pubmed-meshheading:1430680-Humans,
pubmed-meshheading:1430680-Myocardial Infarction,
pubmed-meshheading:1430680-Prognosis,
pubmed-meshheading:1430680-Recombinant Proteins,
pubmed-meshheading:1430680-Recurrence,
pubmed-meshheading:1430680-Thrombolytic Therapy,
pubmed-meshheading:1430680-Tissue Plasminogen Activator,
pubmed-meshheading:1430680-Ventricular Function, Left
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group.
|
|
pubmed:affiliation |
St. Michael's Hospital, Toronto, Ontario, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
